Mackenzie Financial’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.46M | Sell |
68,242
-279,136
| -80% | -$10.1M | ﹤0.01% | 747 |
|
|
2025
Q1 | $10.8M | Buy |
347,378
+205,356
| +145% | +$6.39M | 0.02% | 446 |
|
|
2024
Q4 | $3.62M | Buy |
142,022
+9,313
| +7% | +$238K | ﹤0.01% | 631 |
|
|
2024
Q3 | $3.75M | Buy |
132,709
+123,066
| +1,276% | +$3.48M | 0.01% | 600 |
|
|
2024
Q2 | $254K | Sell |
9,643
-18,742
| -66% | -$494K | ﹤0.01% | 1243 |
|
|
2024
Q1 | $862K | Sell |
28,385
-84,058
| -75% | -$2.55M | ﹤0.01% | 904 |
|
|
2023
Q4 | $3.16M | Buy |
112,443
+92,372
| +460% | +$2.59M | ﹤0.01% | 646 |
|
|
2023
Q3 | $542K | Sell |
20,071
-347
| -2% | -$9.37K | ﹤0.01% | 984 |
|
|
2023
Q2 | $627K | Sell |
20,418
-964
| -5% | -$29.6K | ﹤0.01% | 954 |
|
|
2023
Q1 | $770K | Buy |
+21,382
| New | +$770K | ﹤0.01% | 910 |
|
|
2022
Q4 | – | Sell |
-17,065
| Closed | -$686K | – | 1562 |
|
|
2022
Q3 | $686K | Sell |
17,065
-2,079
| -11% | -$83.6K | ﹤0.01% | 871 |
|
|
2022
Q2 | $805K | Buy |
+19,144
| New | +$805K | ﹤0.01% | 867 |
|
|
2022
Q1 | – | Sell |
-8,856
| Closed | -$353K | – | 1494 |
|
|
2021
Q4 | $353K | Sell |
8,856
-19,678
| -69% | -$784K | ﹤0.01% | 1087 |
|
|
2021
Q3 | $1.03M | Buy |
28,534
+3,634
| +15% | +$131K | ﹤0.01% | 910 |
|
|
2021
Q2 | $1.02M | Hold |
24,900
| – | – | ﹤0.01% | 864 |
|
|
2021
Q1 | $1.09M | Hold |
24,900
| – | – | ﹤0.01% | 799 |
|
|
2020
Q4 | $1.25M | Buy |
+24,900
| New | +$1.25M | ﹤0.01% | 679 |
|